Phase 1 Study of Elotuzumab in Combination With Autologous Stem Cell Transplantation and Lenalidomide Maintenance for Multiple Myeloma
Phase of Trial: Phase I
Latest Information Update: 21 Aug 2017
At a glance
- Drugs Elotuzumab (Primary) ; Aspirin; Dexamethasone; Lenalidomide; Paracetamol
- Indications Multiple myeloma
- Focus Adverse reactions
- 15 Aug 2017 Status changed from recruiting to completed.
- 06 Dec 2016 Results (n=14) assessing safety and tolerability of Elotuzumab presented at the 58th Annual Meeting and Exposition of the American Society of Hematology (2016).
- 28 Jan 2016 New trial record